EP

Epi Biotech Co., Ltd.

Developing alopecia therapies, skin regeneration products, and preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Epi Biotech Co., Ltd. is an advanced biopharmaceutical company specializing in the research and development of treatments for alopecia (hair loss). The company focuses on developing a pipeline of innovative cell and antibody therapies to meet the demand for hair restoration. It also provides preclinical Contract Research Organization (CRO) services for hair loss studies. Additionally, Epi Biotech conducts R&D in skin regeneration treatments with the goal of creating commercially viable consumer products. The company leverages what it describes as South Korea's largest alopecia genomic database to support its research efforts.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Azitra, Inc. Logo
Developing engineered proteins and live biotherapeutics for rare skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Develops T cell immunotherapies for autoimmune and chronic infectious diseases.
United States of America
BRNS
Basilea Pharmaceutica AG Logo
Develops & commercializes anti-infectives for severe bacterial & fungal infections.
Switzerland
BSLN
Bausch Health Companies Inc. Logo
Develops, manufactures, and markets pharmaceuticals, OTCs, and medical devices globally.
United States of America
BHC
Bavarian Nordic Logo
A biotech firm developing and manufacturing life-saving vaccines for travel and public health.
Denmark
BAVA
Bayer AG Logo
A life science firm providing pharmaceuticals, consumer health, and crop science solutions.
Germany
BAY
Beam Therapeutics Inc. Logo
Developing precision genetic medicines using base editing to provide cures for serious diseases.
United States of America
BEAM
BELITE BIO, INC Logo
Developing novel oral therapies for retinal degenerative eye diseases like GA and Stargardt disease.
United States of America
BLTE
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom
BMK

Talk to a Data Expert

Have a question? We'll get back to you promptly.